The stock of Oscar Health Inc (NYSE:OSCR) last traded at $20.74, up 4.91% from the previous session.
OSCR stock price is now 34.30% away from the 50-day moving average and 103.72% away from the 200-day moving average. The market capitalization of the company currently stands at $4.91B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $20, Raymond James recently initiated with Outperform rating for Oscar Health Inc (NYSE: OSCR). On November 02, 2023, BofA Securities Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock increasing its target price from $8 to quote $9, while ‘Wells Fargo’ rates the stock as ‘Overweight’
In other news, Blackley Richard Scott, Chief Financial Officer sold 27,043 shares of the company’s stock on Mar 06 ’24. The stock was sold for $381,847 at an average price of $14.12. Upon completion of the transaction, the Chief Financial Officer now directly owns 614,316 shares in the company, valued at $12.74 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 06 ’24, EVP, Chief Insurance Officer Quane Alessandrea C. sold 13,233 shares of the business’s stock. A total of $186,850 was realized by selling the stock at an average price of $14.12. This leaves the insider owning 212,850 shares of the company worth $4.41 million. A total of 34.10% of the company’s stock is owned by insiders.
During the past 12 months, Oscar Health Inc has had a low of $4.72 and a high of $20.60.
According to the Healthcare Plans Company, earnings per share came in at -0.07, beating analysts’ expectations of -0.23 by 0.16. This compares to -$0.18 EPS in the same period last year. The net profit margin was -0.82% and return on equity was -5.46% for OSCR. The company reported revenue of $2.14 billion for the quarter, compared to $1.47 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 45.77 percent. For the current quarter, analysts expect OSCR to generate $2.1B in revenue.
